OC.12.3 SPOSIB SB2 – A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INFLIXIMAB BIOSIMILAR SB2 (FLIXABI®): INTERIM ANALYSIS

Authors :: Gaetano Inserra
A.C. Privitera
A. Centritto
Giulia Rizzuto
A. Orlando
Maria Cappello
M. Cottone
Fabio Salvatore Macaluso
S. Garufi
A. Magnano
Sara Renna
E. Giuffrida
E. Vinci
Walter Fries
Marco Ventimiglia
R. Vassallo
R. Orlando
Source :: Digestive and Liver Disease. 51:e110
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: medicine.medical_specialty
Hepatology
business.industry
Gastroenterology
Biosimilar
Interim analysis
medicine.disease
Inflammatory bowel disease
Infliximab
Internal medicine
Medicine
Observational study
business
medicine.drug

Full Text Access

Tools